POZEN Inc. Announces Plans to Webcast First-Quarter Earnings Conference Call

Apr 26, 2001, 01:00 ET from POZEN Inc.

    CHAPEL HILL, N.C., April 26 /PRNewswire/ -- POZEN Inc. (Nasdaq:   POZN), a
 pharmaceutical development company with a portfolio of product candidates for
 the treatment of migraine, today announced it plans to conduct a conference
 call following the release of financial results for the first quarter ended
 March 31, 2001.  The company will release earnings before the market opens on
 Monday, April 30, 2001.  John R. Plachetka, Pharm.D., POZEN's chairman,
 president and chief executive officer, and Matthew E. Czajkowski, chief
 financial officer, will host the conference call the same day at 11:00 a.m.
 Eastern Daylight Time.
     The conference call will be simulcast live on the Internet, and can be
 accessed by logging on to http://www.streetevents.com .  A replay will be
 available at this site, as well as on the Investor Relations section of the
 company's website, http://www.pozen.com , for seven days.
 
     North Carolina-based POZEN Inc. is a pharmaceutical development company
 committed to building a portfolio of products with significant commercial
 potential in select therapeutic areas.  The company's initial focus is
 migraine, where it has built a robust portfolio of four product candidates
 through a combination of innovation and in-licensing.  The company's common
 stock is traded on The Nasdaq Stock Market under the symbol "POZN."
 
     POZEN is on the Internet at http://www.pozen.com
 
                     MAKE YOUR OPINION COUNT -  Click Here
                http://tbutton.prnewswire.com/prn/11690X47157875
 
 

SOURCE POZEN Inc.
    CHAPEL HILL, N.C., April 26 /PRNewswire/ -- POZEN Inc. (Nasdaq:   POZN), a
 pharmaceutical development company with a portfolio of product candidates for
 the treatment of migraine, today announced it plans to conduct a conference
 call following the release of financial results for the first quarter ended
 March 31, 2001.  The company will release earnings before the market opens on
 Monday, April 30, 2001.  John R. Plachetka, Pharm.D., POZEN's chairman,
 president and chief executive officer, and Matthew E. Czajkowski, chief
 financial officer, will host the conference call the same day at 11:00 a.m.
 Eastern Daylight Time.
     The conference call will be simulcast live on the Internet, and can be
 accessed by logging on to http://www.streetevents.com .  A replay will be
 available at this site, as well as on the Investor Relations section of the
 company's website, http://www.pozen.com , for seven days.
 
     North Carolina-based POZEN Inc. is a pharmaceutical development company
 committed to building a portfolio of products with significant commercial
 potential in select therapeutic areas.  The company's initial focus is
 migraine, where it has built a robust portfolio of four product candidates
 through a combination of innovation and in-licensing.  The company's common
 stock is traded on The Nasdaq Stock Market under the symbol "POZN."
 
     POZEN is on the Internet at http://www.pozen.com
 
                     MAKE YOUR OPINION COUNT -  Click Here
                http://tbutton.prnewswire.com/prn/11690X47157875
 
 SOURCE  POZEN Inc.